BSX · 10-Q · 2026Q3 · Full report

Stock Repurchase Program

BOSTON SCIENTIFIC CORP · 2026-11-02 · Importance 57 · Surprise 42 · Matches filing data

On February 18, 2026, the board added $4.0 billion to the existing $1.0 billion share-repurchase authorization, bringing the total authorization to $5.0 billion. Under an accelerated share repurchase agreement, Boston Scientific paid JPMorgan $2.0 billion on May 19 and initially received approximately 30 million shares, followed by approximately 10 million additional shares at final settlement on June 12. The company had $3.0 billion remaining under the authorization at September 30, 2026. It had not repurchased shares in the first nine months of 2025.

Key facts

• On February 18, 2026, Boston Scientific's board increased its repurchase authorization by $4.000 billion, from $1.000 billion to a total of $5.000 billion. source
• Boston Scientific paid $2.000 billion under an accelerated share repurchase agreement on May 19, 2026, initially receiving approximately 30 million shares, or approximately 80% of transaction value; final settlement on June 12, 2026 delivered approximately 10 million additional shares. source
• Boston Scientific had $3.000 billion remaining under its share repurchase authorization as of September 30, 2026, and made no common-stock repurchases in the first nine months of 2025. source

Impact estimates